GlaxoSmithKline (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

1,519.00p
   
  • Change Today:
      3.00p
  • 52 Week High: 1,722.00
  • 52 Week Low: 1,452.00
  • Currency: UK Pounds
  • Shares Issued: 4,918.63m
  • Volume: 8,384,497
  • Market Cap: 74,714m
  • RiskGrade: 64

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart (16-10-2017)

6 Month Chart

Financials

Latest F'cast
Div Yield 5.3% 5.3%
Div Cover 1.3 1.4
Op Mrgn 9.3% 26.0%
ROCE 162.9%  
Latest F'cast
P/E 14.8 13.7
PEG 0.4 1.7
Pr/Revenue 2.7 2.5
Pr/Book 15.1  
Latest F'cast
Revenue 16.6% 8.0%
PBT -81.6% 303.3%
EPS 35.3% 7.9%
DPS n/a -0.1%

GlaxoSmithKline Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 26,431.00 6,600.00 111.40p 12.0 n/a -2% 74.00p 5.5%
31-Dec-13 26,505.00 6,647.00 108.40p 14.9 n/a -3% 78.00p 4.8%
31-Dec-14 23,006.00 2,968.00 95.40p 14.4 n/a -12% 80.00p 5.8%
31-Dec-15 23,923.00 10,526.00 75.70p 18.1 n/a -21% 80.00p 5.8%
31-Dec-16 27,889.00 1,939.00 102.40p 15.3 0.4 +35% 80.00p 5.1%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GlaxoSmithKline Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 30,126.60 7,820.61 110.50p 13.7 1.7 +8% 79.95p 5.3%
31-Dec-18 30,816.16 8,037.66 112.93p 13.5 6.1 +2% 80.06p 5.3%

Copyright © 2017 FactSet Research Systems Inc. All rights reserved.

GlaxoSmithKline Company Announcements

Director/PDMR Shareholding 16-Oct-2017 16:52 RNS
Director/PDMR Shareholding 16-Oct-2017 16:42 RNS
Director/PDMR Shareholding 16-Oct-2017 16:40 RNS

Latest GlaxoSmithKline Director Deals

Traded Action Notifier PriceAmountValue
13-Oct-17 Buy Dividends Victoria Whyte 1,519.50p 19 288.70
13-Oct-17 Buy Dividends Dominic Redfern 1,519.50p 23 349.48
13-Oct-17 Buy Dividends Victoria Whyte 1,526.59p 407 6,213.22

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,519.00p
Change Today 3.00p
% Change 0.20 %
52 Week High 1,722.00
52 Week Low 1,452.00
Volume 8,384,497
Shares Issued 4,918.63m
Market Cap 74,714m
RiskGrade 64

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
22.31% below the market average22.31% below the market average22.31% below the market average22.31% below the market average22.31% below the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Price Trend
41.12% below the market average41.12% below the market average41.12% below the market average41.12% below the market average41.12% below the market average
Sector averageSector averageSector averageSector averageSector average
Income
80.73% above the market average80.73% above the market average80.73% above the market average80.73% above the market average80.73% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
11.18% above the market average11.18% above the market average11.18% above the market average11.18% above the market average11.18% above the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average

What The Brokers Say

Strong Buy 12
Buy 2
Neutral 14
Sell 0
Strong Sell 4
Total 32
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q2 Q1
Ex-Div 10-Aug-17 11-May-17
Paid 12-Oct-17 13-Jul-17
Amount 19.00p 19.00p

Trades for 16-Oct-2017

Time Volume / Share Price
17:06 1,770 @ 1,518.05p
17:06 1,770 @ 1,518.05p
17:03 113,129 @ 1,518.78p
17:03 113,129 @ 1,518.78p
17:03 2,069 @ 1,518.96p

GlaxoSmithKline Key Personnel

CFO Simon Dingemans
CEO Emma Walmsley

Top of Page